Furthermore, chronic remedy with 30 mol/L trans-10, cis-12 CLA, but now not cis-nine, trans-eleven CLA, reduced the expression Lipo CLA of the insulin-inspired glucose transporter 4 (GLUT4) and acetyl-CoA carboxylase (ACC), the price-figuring out enzyme in de novo fatty acid synthesis (22). Collectively, supplementation with trans-10, cis-12, however now not cis-9, trans-eleven.